• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管疾病与人参:分子机制与医学应用综述。

Cardiovascular Diseases and Panax ginseng: A Review on Molecular Mechanisms and Medical Applications.

机构信息

Department of Veterinary Physiology, College of Veterinary Medicine, Biosafety Research Institute, Chonbuk National University, Jeonju 561-756, Korea.

出版信息

J Ginseng Res. 2012 Jan;36(1):16-26. doi: 10.5142/jgr.2012.36.1.16.

DOI:10.5142/jgr.2012.36.1.16
PMID:23717100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3659571/
Abstract

Ginseng is one of the most widely used herbal medicines and is reported to have a wide range of therapeutic and pharmacological applications. Ginseng may also be potentially valuable in treating cardiovascular diseases. Research concerning cardiovascular disease is focusing on purified individual ginsenoside constituents of ginseng to reveal specific mechanisms instead of using whole ginseng extracts. The most commonly studied ginsenosides are Rb1, Rg1, Rg3, Rh1, Re, and Rd. The molecular mechanisms and medical applications of ginsenosides in the treatment of cardiovascular disease have attracted much attention and been the subject of numerous publications. Here, we review the current literature on the myriad pharmacological functions and the potential benefits of ginseng in this area. In vitro investigations using cell cultures and in vivo animal models have indicated ginseng's potential cardiovascular benefits through diverse mechanisms that include antioxidation, modifying vasomotor function, reducing platelet adhesion, influencing ion channels, altering autonomic neurotransmitters release, and improving lipid profiles. Some 40 ginsenosides have been identified. Each may have different effects in pharmacology and mechanisms due to their different chemical structures. This review also summarizes results of relevant clinical trials regarding the cardiovascular effects of ginseng, particularly in the management of hypertension and improving cardiovascular function.

摘要

人参是最广泛使用的草药之一,据报道具有广泛的治疗和药理学应用。人参在治疗心血管疾病方面也可能具有潜在的价值。有关心血管疾病的研究侧重于人参中纯化的单个人参皂甙成分,以揭示特定的机制,而不是使用全人参提取物。研究最多的人参皂甙是 Rb1、Rg1、Rg3、Rh1、Re 和 Rd。人参皂甙在治疗心血管疾病中的分子机制和医学应用引起了广泛关注,并有大量出版物对此进行了报道。在这里,我们综述了目前关于人参在这一领域的众多药理学功能和潜在益处的文献。细胞培养和体内动物模型的体外研究表明,人参通过多种机制具有潜在的心血管益处,包括抗氧化、调节血管舒缩功能、减少血小板黏附、影响离子通道、改变自主神经递质释放以及改善血脂谱。已经鉴定出大约 40 种人参皂甙。由于它们的化学结构不同,每种皂甙在药理学和机制上可能具有不同的作用。本综述还总结了人参对心血管影响的相关临床试验结果,特别是在高血压的治疗和改善心血管功能方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f850/3659571/e66be074e2ad/grosbr-36-16-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f850/3659571/80512cd93f5d/grosbr-36-16-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f850/3659571/e66be074e2ad/grosbr-36-16-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f850/3659571/80512cd93f5d/grosbr-36-16-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f850/3659571/e66be074e2ad/grosbr-36-16-g002.jpg

相似文献

1
Cardiovascular Diseases and Panax ginseng: A Review on Molecular Mechanisms and Medical Applications.心血管疾病与人参:分子机制与医学应用综述。
J Ginseng Res. 2012 Jan;36(1):16-26. doi: 10.5142/jgr.2012.36.1.16.
2
A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases.人参及人参皂苷对心血管疾病药用潜能的综述。
J Ginseng Res. 2014 Jul;38(3):161-6. doi: 10.1016/j.jgr.2014.03.001. Epub 2014 Apr 3.
3
Ginseng compounds: an update on their molecular mechanisms and medical applications.人参化合物:其分子机制与医学应用的最新进展
Curr Vasc Pharmacol. 2009 Jul;7(3):293-302. doi: 10.2174/157016109788340767.
4
Pharmacological and medical applications of and ginsenosides: a review for use in cardiovascular diseases.人参皂苷的药理及医学应用:用于心血管疾病的综述
J Ginseng Res. 2018 Jul;42(3):264-269. doi: 10.1016/j.jgr.2017.10.004. Epub 2017 Oct 21.
5
Molecular mechanisms and clinical applications of ginseng root for cardiovascular disease.人参根对心血管疾病的分子机制及临床应用
Med Sci Monit. 2004 Aug;10(8):RA187-92. Epub 2004 Jul 23.
6
A literature update elucidating production of Panax ginsenosides with a special focus on strategies enriching the anti-neoplastic minor ginsenosides in ginseng preparations.阐明人参皂苷生产的文献更新,特别关注在人参制剂中富集具有抗肿瘤作用的低含量人参皂苷的策略。
Appl Microbiol Biotechnol. 2017 May;101(10):4009-4032. doi: 10.1007/s00253-017-8279-4. Epub 2017 Apr 14.
7
Bioactivity-guided identification and cell signaling technology to delineate the immunomodulatory effects of Panax ginseng on human promonocytic U937 cells.生物活性导向鉴定及细胞信号技术用于阐明人参对人原单核细胞U937细胞的免疫调节作用。
J Transl Med. 2009 May 14;7:34. doi: 10.1186/1479-5876-7-34.
8
Comparison of the pharmacological effects of Panax ginseng and Panax quinquefolium.人参和西洋参药理作用的比较。
Acta Pharmacol Sin. 2008 Sep;29(9):1103-8. doi: 10.1111/j.1745-7254.2008.00868.x.
9
Effects and mechanisms of ginseng and ginsenosides on cognition.人参及人参皂苷对认知的影响与机制。
Nutr Rev. 2014 May;72(5):319-33. doi: 10.1111/nure.12099. Epub 2014 Mar 25.
10
Role of ginsenosides, the main active components of , in inflammatory responses and diseases.人参皂苷(人参的主要活性成分)在炎症反应和疾病中的作用。
J Ginseng Res. 2017 Oct;41(4):435-443. doi: 10.1016/j.jgr.2016.08.004. Epub 2016 Aug 18.

引用本文的文献

1
Integrated Analysis of GC-MS-Based Metabolomics and Proteomics Reveals the Importance of Volatile Metabolite Stigmasterol in the Defence Response of Panax notoginseng Against Root Rot.基于气相色谱-质谱联用的代谢组学和蛋白质组学的综合分析揭示了挥发性代谢物豆甾醇在三七对根腐病防御反应中的重要性。
Mol Plant Pathol. 2025 Sep;26(9):e70144. doi: 10.1111/mpp.70144.
2
Ginsenoside Rb1 mitigates atherosclerosis in part through modulating FTO-mediated mA RNA modification in NETs-induced endothelial activation.人参皂苷Rb1部分通过调节FTO介导的NETs诱导的内皮细胞活化中的m⁶A RNA修饰来减轻动脉粥样硬化。
Front Pharmacol. 2025 Jul 23;16:1631076. doi: 10.3389/fphar.2025.1631076. eCollection 2025.
3

本文引用的文献

1
Ginseng protects rodent hearts from acute myocardial ischemia-reperfusion injury through GR/ER-activated RISK pathway in an endothelial NOS-dependent mechanism.人参通过内皮型一氧化氮合酶(endothelial nitric oxide synthase,eNOS)依赖的机制,通过葡萄糖调节蛋白(glucose regulated protein,GR)/内质网应激激活的复苏诱导激酶(reperfusion injury salvage kinase,RISK)通路保护啮齿动物心脏免受急性心肌缺血再灌注损伤。
J Ethnopharmacol. 2011 May 17;135(2):287-98. doi: 10.1016/j.jep.2011.03.015. Epub 2011 Mar 17.
2
Use of ginseng to reduce post-myocardial adverse myocardial remodeling: applying scientific principles to the use of herbal therapies.使用人参减少心肌梗死后不良心肌重塑:将科学原理应用于草药疗法的使用
J Mol Med (Berl). 2011 Apr;89(4):317-20. doi: 10.1007/s00109-011-0736-4.
3
Can Panax ginseng help protect the body from the harmful effects of airborne particulate matter?
人参能帮助保护身体免受空气中颗粒物的有害影响吗?
J Ginseng Res. 2025 Jul;49(4):331-341. doi: 10.1016/j.jgr.2025.03.001. Epub 2025 Mar 4.
4
Monoclonal antibody-based enzyme-linked immunosorbent assay for quantification of majonoside R2 as an authentication marker for Nngoc Linh and Lai Chau ginsengs.基于单克隆抗体的酶联免疫吸附测定法用于定量测定大戟苷R2,作为宁顺和莱州人参的鉴定标志物。
J Ginseng Res. 2024 Sep;48(5):474-480. doi: 10.1016/j.jgr.2024.05.004. Epub 2024 May 23.
5
Use of Herbal Drugs in Cardiovascular Disease- A Review.草药在心血管疾病中的应用——综述
Curr Cardiol Rev. 2025;21(1):e1573403X323724. doi: 10.2174/011573403X323724240830075719.
6
Update on clinical and experimental management of diabetic cardiomyopathy: addressing current and future therapy.糖尿病心肌病的临床和实验治疗进展:关注当前和未来的治疗策略。
Front Endocrinol (Lausanne). 2024 Jul 30;15:1451100. doi: 10.3389/fendo.2024.1451100. eCollection 2024.
7
Cardiovascular Effects of Herbal Products and Their Interaction with Antihypertensive Drugs-Comprehensive Review.草药产品对心血管的影响及其与抗高血压药物的相互作用——综合评价。
Int J Mol Sci. 2024 Jun 9;25(12):6388. doi: 10.3390/ijms25126388.
8
Exploring the pathways of drug repurposing and Panax ginseng treatment mechanisms in chronic heart failure: a disease module analysis perspective.探讨药物再利用和人参治疗慢性心力衰竭的作用机制的途径:从疾病模块分析的角度。
Sci Rep. 2024 May 27;14(1):12109. doi: 10.1038/s41598-024-61926-2.
9
A Systematic Review of Herbal Interventions for the Management of Cardiovascular Diseases.草药干预治疗心血管疾病的系统评价。
Curr Cardiol Rev. 2024;20(5):e030524229664. doi: 10.2174/011573403X286573240422104647.
10
The Potential of Natural Products in the Management of Cardiovascular Disease.天然产物在心血管疾病管理中的潜力。
Curr Pharm Des. 2024;30(8):624-638. doi: 10.2174/0113816128295053240207090928.
Compound K, a metabolite of ginsenosides, induces cardiac protection mediated nitric oxide via Akt/PI3K pathway.化合物 K,一种人参皂苷的代谢产物,通过 Akt/PI3K 通路诱导心脏保护作用的一氧化氮。
Life Sci. 2011 Apr 11;88(15-16):725-9. doi: 10.1016/j.lfs.2011.02.011. Epub 2011 Feb 19.
4
Making a case for quantitative assessment of cardiovascular risk.为心血管风险的定量评估提供依据。
J Clin Lipidol. 2007 Aug;1(4):234-41. doi: 10.1016/j.jacl.2007.07.002.
5
Ginsenoside-Rg1 mediates microenvironment-dependent endothelial differentiation of human mesenchymal stem cells in vitro.人参皂苷-Rg1介导人间充质干细胞在体外微环境依赖性内皮分化。
J Asian Nat Prod Res. 2011 Jan;13(1):1-11. doi: 10.1080/10286020.2010.535519.
6
Effect of Korean red ginseng on arterial stiffness in subjects with hypertension.红参对高血压患者动脉僵硬的影响。
J Altern Complement Med. 2011 Jan;17(1):45-9. doi: 10.1089/acm.2010.0065. Epub 2011 Jan 16.
7
Ginsenoside-Rd, a purified component from panax notoginseng saponins, prevents atherosclerosis in apoE knockout mice.人参皂苷-Rd 是从三七总皂苷中提取的一种有效单体成分,能预防载脂蛋白 E 基因敲除小鼠的动脉粥样硬化。
Eur J Pharmacol. 2011 Feb 10;652(1-3):104-10. doi: 10.1016/j.ejphar.2010.11.017. Epub 2010 Nov 29.
8
Protective effect of ginsenoside Rb1 against myocardial ischemia/reperfusion injury in streptozotocin-induced diabetic rats.人参皂苷 Rb1 对链脲佐菌素诱导的糖尿病大鼠心肌缺血/再灌注损伤的保护作用。
Mol Biol Rep. 2011 Oct;38(7):4327-35. doi: 10.1007/s11033-010-0558-4. Epub 2010 Nov 27.
9
Hypolipidemic and antioxidant activities of sanchi (radix notoginseng) in rats fed with a high fat diet.高脂饮食大鼠桑枝(三七)的降血脂和抗氧化活性。
Phytomedicine. 2011 Apr 15;18(6):516-20. doi: 10.1016/j.phymed.2010.09.007. Epub 2010 Oct 30.
10
Ginseng inhibits cardiomyocyte hypertrophy and heart failure via NHE-1 inhibition and attenuation of calcineurin activation.人参通过抑制 NHE-1 和减弱钙调神经磷酸酶的激活来抑制心肌细胞肥大和心力衰竭。
Circ Heart Fail. 2011 Jan;4(1):79-88. doi: 10.1161/CIRCHEARTFAILURE.110.957969. Epub 2010 Oct 22.